X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked stroke-like episodes: A case report
Qiang Zhang, Yang Wang, Run-Tao Bai, Bao-Rong Lian, Yu Zhang, Li-Ming Cao
Qiang Zhang, Yang Wang, Run-Tao Bai, Li-Ming Cao, Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, Guangdong Province, China
Bao-Rong Lian, Shantou University Medical College, Shantou University, Shantou 515063, Guangdong Province, China
Yu Zhang, Clinical College of The Shenzhen Second People's Hospital, Anhui Medical University, Shenzhen 518000, Guangdong Province, China
Li-Ming Cao, Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha 410219, Hunan Province, China
Author contributions: Cao LM was involved in writing, diagnosis confirmation, and conceptualization; Zhang Q and Wang Y were involved in writing, constructive discussion, and literature review; Zhang Y, Lian BR, and Bai RT provided constructive discussion; All authors have read and approved the final manuscript; Zhang Q and Wang Y contributed equally to this work and share first authorship.
Supported by Shenzhen Science and Technology Project, No. SGLH20180628161804465; and The Clinical Research Project of The First Affiliated Hospital of Shenzhen University, No. 20203357035 and No. 20223357021.
Informed consent statement: The study design was approved by the ethics review board of the First Affiliated Hospital of Shenzhen University (No: 20220115006). Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Li-Ming Cao, MD, PhD, Research Scientist, Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, No. 1501 Leifeng Avenue, Wangcheng District, Changsha 410219, Hunan Province, China. caolm-2007@163.com
Received: November 6, 2022
Peer-review started: November 6, 2022
First decision: November 16, 2022
Revised: November 18, 2022
Accepted: January 3, 2023
Article in press: January 3, 2023
Published online: January 16, 2023
Processing time: 66 Days and 16.5 Hours